Literature DB >> 16595149

Incidence of ovarian cancer of grand multiparous women--a population-based study in Finland.

Marianne Hinkula1, Eero Pukkala, Pentti Kyyrönen, Antti Kauppila.   

Abstract

OBJECTIVES: Parity is known to induce protective effects on ovarian cancer. This study aimed to evaluate how far upon births the protection reaches, the effect of age at first birth, the interval between births in the whole population and the length of time from the first to the last birth and from the last birth to cancer among postmenopausal women.
METHOD: The population-based cohort consisted of 87,929 grand multiparous (GM) women, i.e. women with at least 5 deliveries. Standardised incidence ratios (SIRs) were calculated by dividing the number of observed cancer cases by the expected number based on the national incidence rates, both extracted from the population-based Finnish Cancer Registry. Conditional logistic regression for the case-control design nested in the GM cohort was used to estimate proportional hazards by different factors.
RESULTS: The SIR for ovarian cancer among GM women was low (418 cases; SIR 0.64, 95% confidence interval 0.58-0.69). Further births over five did not give additional protection. The relative risk did not vary significantly by age at first birth or interval between the births in any histological subtype.
CONCLUSION: The risk of ovarian cancer was low in all GM women no matter how many children and at which ages they had delivered or contracted cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16595149     DOI: 10.1016/j.ygyno.2006.02.025

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Recent progress in the diagnosis and treatment of ovarian cancer.

Authors:  Danijela Jelovac; Deborah K Armstrong
Journal:  CA Cancer J Clin       Date:  2011-04-26       Impact factor: 508.702

2.  Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.

Authors:  Elizabeth M Poole; Melissa A Merritt; Susan J Jordan; Hannah P Yang; Susan E Hankinson; Yikung Park; Bernard Rosner; Penelope M Webb; Daniel W Cramer; Nicolas Wentzensen; Kathryn L Terry; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-10       Impact factor: 4.254

3.  Estrogen combined with progesterone decreases cell proliferation and inhibits the expression of Bcl-2 via microRNA let-7a and miR-34b in ovarian cancer cells.

Authors:  Y L Xie; Y J Yang; C Tang; H J Sheng; Y Jiang; K Han; L J Ding
Journal:  Clin Transl Oncol       Date:  2014-03-19       Impact factor: 3.405

4.  Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors.

Authors:  Sarah Miller; Nobel Bhasin; Heather Urrego; Krzysztof Moroz; Brian G Rowan; Meera S Ramayya; Nick M Makridakis
Journal:  Int J Oncol       Date:  2012-12-28       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.